Skip to content

To evaluate the clinical trial of laparoscopic complicated upper urinary tract reconstruction, adrenalectomy and nephrectomy assisted by laparoscopic surgery system

To evaluate the clinical trial of laparoscopic complicated upper urinary tract reconstruction, adrenalectomy and nephrectomy assisted by laparoscopic surgery system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086404
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-08-14
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex upper urinary tract reconstruction, adrenalectomy and nephrectomy

Interventions

test group:Complete complex upper urinary tract reconstruction (including ileal ureteroplasty and autogenous patch ureteroplasty), adrenalectomy and nephrectomy with laparoscopic surgery system.

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 18-75 years old, regardless of gender; Those who agree to sign the informed consent form and can follow the doctor's advice and make regular follow-up visits. Complicated upper urinary tract reconstruction surgery: patients with complicated long ureteral stricture who need ileal ureteroplasty or autogenous patch ureteroplasty; Adrenalectomy: patients suffering from benign and malignant adrenal tumors, hypercortisolism and primary aldosteronism, etc., who need unilateral partial or total adrenalectomy according to the researcher's judgment; Benign adrenal tumor with diameter less than 6 cm; Small adrenal malignant tumor; Adrenal cortical carcinoma with small tumor and no invasion of surrounding organs; Primary aldosteronism caused by unilateral adrenocortical hyperplasia or aldosteroma was diagnosed, and unilateral adrenalectomy was performed; Nephrectomy is diagnosed as renal tumor, renal tuberculosis, hydronephrosis, kidney calculi's disease, pyonephrosis or severe renal injury, etc., and the researcher determines that partial nephrectomy or radical nephrectomy is feasible; Unilateral kidney surgery; Partial nephrectomy: TNM stage of tumor was T1aN0M0;; Radical nephrectomy: TNM staging of tumor was T1bN0M0, T2NOMO, T3aNxM0 and T3aN0M0;

Exclusion criteria

Exclusion criteria: Does not meet the selection criteria; There is abnormal blood coagulation function that is difficult to correct; Have a serious uncontrolled disease or acute infection; Cardiovascular and cerebrovascular diseases, blood system diseases and diabetes can not be controlled and can not meet the surgical standards; Have immune system diseases that can't be controlled and can't meet the surgical standards; Patients with previous abdominal and pelvic surgery history and severe abdominal and pelvic adhesion; The researcher thinks that it is not suitable for inclusion. Adrenalectomy, pheochromocytoma or paraganglioma with diameter =6 cm or invasion; Imaging suggests adrenal tumors with adjacent organ invasion or distant metastasis;

Design outcomes

Primary

MeasureTime frame
The operation can be completed according to the established surgical plan;No conversion to open surgery, laparoscopic surgery and other surgical procedures during the operation.;

Secondary

MeasureTime frame
Obstruction of ureteropelvic junction is relieved;The intraoperative blood loss, intraoperative blood transfusion and postoperative 24-hour drainage were recorded. All adverse events during the test were recorded.;Surgical complications;

Countries

China

Contacts

Public ContactTian Ye

Guizhou Provincial People's Hospital

tianye5055@163.com+86 173 8501 5539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026